FDA Approves First Postpartum Depression Drug
For the first time in history, the US Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians. On Tuesday, the FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It has been shown in clinical trials to work within hours to treat the symptoms of postpartum depression, a serious mental illness that impacts 1 in 9…
Read more
Read more
Popular
-
Avocado Recall: Escondido Company Recalls Fruit Due to Possible Health Risk
-
Infant Airlifted in Critical Condition, Horse Killed in Major Pile-Up on I-5 Freeway Near Gorman
-
Man Arrested After Kicking 78-Year-Old Woman in the Face Multiple Times on New York City Subway
-
Two Dead, One Seriously Injured in South Sacramento Stabbing near Florin Road; Suspect Outstanding
-
More Than 12,000 Cases of Pillsbury Flour Recalled Over Salmonella Concerns
-
Facebook Says Outages Due to ‘Server Configuration Change’
-
You’re Not Alone: Facebook, Instagram Down for Many Across World
-
US Senate to Hold Hearing on Air Safety Following Ethiopia Plane Crash
-
Google Paid Former Exec $35 Million after Harassment Claim
-
-
Honda Recalls 1.2M More Vehicles with Dangerous Air Bags
-
Airbnb Acquires Last-Minute Booking Service HotelTonight
-
Warner Bros. Chair Being Investigated for Sexual Misconduct
-
Mario Batali Gives Up Financial Stake in All His Restaurants
-
Gap to Split Into 2, with Old Navy Gaining Independence
-
?>
-
Calling All Chocolate Lovers! Cadbury’s Parent Company is Hiring Chocolate Tasters
-
Victoria’s Secret to Close 53 Stores
